SlideShare a Scribd company logo
Adapted from Lawrence DT and Kirk MA, Chemical Terrorism Attacks: Update on Antidotes. Emerg Med Clin N Am 25 (2007) 567–595
Chemical Terrorism Attacks: Update on Antidotes
Nerve agents
 Vapour exposures immediate symptoms (seconds to minutes)
 Dermal exposures delayed (minutes to 18 hours)
Farooq Khan MDCM
PGY3 FRCP-EM
McGill University
November 14
th
2011
Adapted from Lawrence DT and Kirk MA, Chemical Terrorism Attacks: Update on Antidotes. Emerg Med Clin N Am 25 (2007) 567–595
Mark-1 Kit
Atropine
Mechanism Atropine acts at muscarinic cholinergic receptors as a competitive antagonist. It is used to counter
muscarinic effects, and administration will result in drying of secretions, alleviating bronchospasm, and reversing central
apnea. Given within the first 5 minutes, it can prevent organophosphate-induced seizures
Delivery autoinjector is more effective than IM injections using a conventional syringe, can go through clothing or
protective garments. Additional atropine doses should be administered IV once access is obtained
Dosing
 Field treatment for severe poisoning is three autoinjectors or 6 mg initially with retreatment q 5-10 min
 The initial intravenous dose should be 2 mg for adults or 0.02 mg/kg for children
 Atropine doses should be repeated q 5 min until the therapeutic endpoint is reached (ie, until pulmonary
secretions are dried [reflected by improved oxygenation] and ease of breathing [or ease of ventilation])
 Typical total dose required after nerve agent poisoning has ranged from 5 to 20 mg (up to 200mg in cases)
Precautions. Excessive doses of atropine can result in deleterious effects including delirium, agitation, and tachycardia
and hypertension. Atropine will likely not improve miosis or skeletal muscle paralysis; therefore, reversal of these effects
is not a therapeutic endpoint.
Benzodiazepines
Indications
 Any patient who has significant symptoms from nerve agent exposure to prevent seizure and neuronal damage
 Infused rapidly to unresponsive patients who may have nonconvulsive seizures due to the onset of paralysis
 Alleviate extreme anxiety
Adapted from Lawrence DT and Kirk MA, Chemical Terrorism Attacks: Update on Antidotes. Emerg Med Clin N Am 25 (2007) 567–595
Dose/delivery
Diazepam 10 mg IM auto-injector in the field, Midazolam IM/IV in hospital
2-PAM
 Neither atropine nor benzodiazepines will alleviate symptoms affecting the nicotinic system.
 Over time, nerve agents will form an irreversible covalent bond with AChE in a process termed aging.
 Once aging occurs, the patient will not regain vital functions, such as muscle strength or respiratory drive, until
new enzyme is synthesized (may take weeks to months)
 Oxime reactivates AChE if administered before aging
Indications. 2-PAM should be given to any patient exposed to an organophosphate nerve agent who is showing any
systemic toxicity. This is particularly true if there are fasciculations or weakness.
Dose/Delivery
Mark 1 auto-injector 600mg IM per dose for the field (max
3 injections). IV preferred in hospital.
 Initial dose is 1- 2 g diluted in 100mL normal saline
and given over 15-30 min
 Initial pediatric dose is 20 to 50 mg/kg up to 2 g
 WHO recommendation >30mg/kg bolus then
>8mg/kg/hour infusion to maintain therapeutic levels
due to short t½ (90 min)
 For severely poisoned patients: 2 g IM or slow IV
infusion over 15-30 minutes then 500mg/h infusion.
Precautions. Rapid delivery can cause laryngospasm,
rigidity, and self-limited hypertension responding to
phentolamine 5 mg IV
Pediatrics
 ↑minute ventilation/kg → ↑ risk with exposure
 Small airways with bronchospasm and ↑secretions→ ↑rates of respiratory distress/failure
 ↑prone to seizures
 The dose for atropine can be up to 0.05 - 0.1 mg/kg either IV/IO/IM.
 40 kg can be administered an adult (2 mg) autoinjector
 20 kg can receive a 1-mg autoinjector
 10 kg can receive a 0.5-mg autoinjector
 The dose for 2-PAM is 25 to 50 mg/kg, up to a total of 2 g.
 12 kg will be able to tolerate the dose of one 600-mg 2-PAM autoinjector
 Diazepam should be dosed at 0.05 to 0.3 mg/kg IV,
 > 30 kg can receive an adult autoinjector
 Autoinjector needle is 1 inch, so choose site carefully
Stockpile antidotes if stocks run out, glycopyrrolate (no central effects), scopolamine (more potent central
effects), diphenhydramine, and jimsonweed extract can be used as alternatives
Adapted from Lawrence DT and Kirk MA, Chemical Terrorism Attacks: Update on Antidotes. Emerg Med Clin N Am 25 (2007) 567–595
Cyanide
Found in smoke inhalation, industrial accidents, suicide attempts, criminal poisonings and can be potent chemical
weapon.
Primary toxic action is inducing cellular hypoxia through inhibition of cytochrome oxidase, blocking oxidative
phosphorylation → shift from aerobic to anaerobic metabolism causes a depletion of cellular ATP and ↑lactic acid
Effects depend on dose/route/timing
o CNS and cardiac toxicity because these are the most O2-sensitive systems
o Concentrated exposure→ death within minutes (i.e. no time for medical intervention)
o Lesser exposure→ nonspecific symptoms including shortness of breath, hyperventilation, headache,
weakness, and dizziness, which can be attributed to anxiety or other exposures
o Progression to confusion, lethargy, seizures, and coma.
o Neurally mediated tachypnea along with an initial ↑BP
o Can progress to cardiac arrest heralded by bradycardia and hypotension
o Cherry red color and ↑O2 Sat
Cyanide antidote kit
Amyl nitrite, sodium nitrite, and sodium thiosulfate
Adapted from Lawrence DT and Kirk MA, Chemical Terrorism Attacks: Update on Antidotes. Emerg Med Clin N Am 25 (2007) 567–595
Mechanism
o Nitrites (amyl and sodium) induce methemoglobinemia
o Cyanide has a ↑affinity for methemoglobin and will leave the mitochondria to bind to it and allow the
mitochondria to resume oxidatitive phosphorylation.
o Sodium thiosulfate acts as a sulfhydryl donor for the enzyme for the enzyme rhodanese that converts cyanide to
the less-toxic renally excreted thiocyanate
Indications to initiate therapy
 High index of suspicion
o clusters of patients, structural fire victim, high risk activity (e.g. jeweller, lab worker)
 Clinical presentations
o sudden LOC, seizures, HD instability without probable cause
 Surrogate markers
o lactate, metabolic acidoses, narrow arteriovenous O2 Sat gap
Dose/delivery
 Crush amyl nitrite glass pearls and inhale or administer via BMV until IV line (goal to induce 3-5% MetHb)
 Then switch to sodium nitrite IV 300mg (10ml of 3% sol’n) over 2-4min,
 Peds: 10mg/kg with normal Hb, 6mg/kg in anemic or unknown Hb child
 Sodium thiosulfate 12.5g IV (50ml of 25% sol’n) over 10 min, peds 1.65ml/kg of 25% sol’n
 Give with high-level O2 , charcoal for oral exposures
Precautions
 Vasodilation, tachycardia, hypotension with high doses of nitrite
 ↓ O2 carrying capacity with MetHb, avoid in anemic, CO poisoned
 Thiosulfate can cause hemolysis in G6PD deficiency
 Thiocyanate can be toxic in renal failure (abdo pain, rash, vomiting, CNS dysfunction)
Hydroxycobalamin
 Combines with CN to cyanocobalamin a.k.a. Vitamin B12 (safe and renally excreted)
 Low threshold of administration given safety profile
 Dose
o 70mg/kg, max 5g(adult dose) IV over 15 min
o Each vial of 250ml contains 2.5g, which needs to be diluted in 100ml of NS to bind 250mg of CN
o Repeat dosing in severe toxicity
 Combine with sodium thiosulfate but either sequentially or in a different line (inactivated if in the same line)
 scavenges NO and prevents hypotension
 transient red discoloration of skin and mucus membranes, interferes with lab assays of bili, creat, mg, fe
 otherwise safe and preferred over nitrites
Mass exposure
 Most patients will not have significant exposures
 Patients presenting in cardiac arrest will have low survival
 Reserve antidotes for those most likely to survive
 Can use thiosulfate alone
Adapted from Lawrence DT and Kirk MA, Chemical Terrorism Attacks: Update on Antidotes. Emerg Med Clin N Am 25 (2007) 567–595
Botulism
 Clostridial toxins A, B, E, and F
 Highly potent (LD 50 of 1μg/kg)
 Food water (onset 2h-5 days), aerosolized (onset 3 days), injection
 Prevents fusion of synaptic vesicles with presynaptic membrane in PNS (cannot cross BBB) prevents
neurotransmission
 Descending weakness, EOMs and bulbar cranial nerves (diplopia/dysarthria/dysphagia) then motor function of
UE then LE. Can affect intercostals and diaphragm needing mechanical ventilation. Spared sensory and
mentation.
 Anti-muscarinic effects and nausea vomiting precede neurologic symptoms
 Paralysis is irreversible until cleaved protein is regenerated which can last months
Antitoxin
 halts progression of paralysis
 binds and neutralizes free botulinum toxin
 indicated on clinical suspicion (clusters of patients with similar geography etc)
 dose 1 vial of Ig IV over 30-60 min diluted 1:10 in NS
 1% allergic reaction to horse serum based Ig
 Baby-BIG is human derived and recommended in infants
Thallium
 Less well known toxic heavy metal odourless and colorless dissolved in water (used in myocardial scintigraphy)
 Minimum lethal dose of 12mg/kg
 Absorbed from GI tract, causes green discoloration of urine in 1h
 Unclear if Interferes with Krebs cycle, glycolysis, and oxidative phosphorylation, or forms stable complexes with
the active sulfhydryl sites on enzymes
 Nonspecific symptoms (early GI, mostly neuro)
 Reliable early clue for thallium toxicity is an ascending, rapidly progressive painful sensory peripheral
neuropathy (feet)
 Delayed alopecia (weeks)
Prussian Blue
 Enhances elimination by blocking enteroenteric and enterohepatic recirculation of thallium
 Indicated for any patient with toxicity or known exposure
 150-250 mg/kg/day divided tid until urinary thallium excretion is <0.5mg/day
 No side effects except blue tears and constipation (Dissolve in 50ml of 15% mannitol as cathartic)
 Can use activated charcoal as alternative if in low supply of Prussian blue
Adapted from Lawrence DT and Kirk MA, Chemical Terrorism Attacks: Update on Antidotes. Emerg Med Clin N Am 25 (2007) 567–595
Radiation
Potassium iodide (KI)
 Prevents thyroid cancer in patients exposed to radioactive iodine
 Subtotal protection
 Must be administered within hours
 Indications
o Children, pregnant or lactating women with >0.05 Gy exposure
o Adults over 40 with dose >5 Gy
 Dose
o Newborn – 1 month: 16 mg po qd
o Infants and children <3 : 32 mg po qd
o Children 3-18: 65 mg po qd
o Adults: 130 mg po qd
Prussian blue
 For cesium-137 (used in radiotherapy and medical devices, could be used in dirty bomb), behaves like
potassium. Physiological t½ of 50-150 days, renally excreted in 4:1 ratio with fecal excretion
 ↓urine/feces excretion ratio to 1:4 and ↓t ½ by 43%
 Dose 3-10g/day
 FDA recommendation : 3g bid for adults, 1g tid for children 2-12 ×30days
 Mostly non toxic and not absorbed, although not studied in ARS GI syndrome where there is severe
inflammation of mucosa.

More Related Content

Similar to Chemical terrorism attacks - update on antidotes - handout

Medicine 5th year, 3rd lecture (Dr. Mohammad Shaikhani)
Medicine 5th year, 3rd lecture (Dr. Mohammad Shaikhani)Medicine 5th year, 3rd lecture (Dr. Mohammad Shaikhani)
Medicine 5th year, 3rd lecture (Dr. Mohammad Shaikhani)
College of Medicine, Sulaymaniyah
 
Cns Mg Davidson 07.
Cns Mg Davidson 07.Cns Mg Davidson 07.
Cns Mg Davidson 07.
Shaikhani.
 
Antihelminthiasis.pptx
Antihelminthiasis.pptxAntihelminthiasis.pptx
Antihelminthiasis.pptx
Anant Khot
 
Myasthenia-Gravis.pptx
Myasthenia-Gravis.pptxMyasthenia-Gravis.pptx
Myasthenia-Gravis.pptx
ARRaneem
 
Intravenous Induction Agents by Dr. Animesh
Intravenous Induction Agents by Dr. AnimeshIntravenous Induction Agents by Dr. Animesh
Intravenous Induction Agents by Dr. Animesh
19anisingh
 
Non narcotic analgesics
Non narcotic analgesicsNon narcotic analgesics
Non narcotic analgesics
Sharique Ayaz
 
Disorders of the neuromuscular junction
Disorders of the neuromuscular junctionDisorders of the neuromuscular junction
Disorders of the neuromuscular junction
Neurology Residency
 
status epilepticus...
status epilepticus...status epilepticus...
status epilepticus...
NeurologyKota
 
Treatment of Different Types of Pain.pdf
Treatment of Different Types of Pain.pdfTreatment of Different Types of Pain.pdf
Treatment of Different Types of Pain.pdf
Aarifa Munny
 
Myasthenia gravis sh
Myasthenia gravis shMyasthenia gravis sh
Myasthenia gravis sh
Shivaom Chaurasia
 
General anesthetics
General anestheticsGeneral anesthetics
General anesthetics
vedastekarorero
 
Drugs used in emergency and operation theatre
Drugs used in emergency and operation theatreDrugs used in emergency and operation theatre
Drugs used in emergency and operation theatre
RUCHIT PATEL
 
Intravenous induction agents
Intravenous induction agentsIntravenous induction agents
Intravenous induction agents
Deepali Jamgade
 
Myasthenia gravis
Myasthenia gravisMyasthenia gravis
Myasthenia gravis
ashabdou
 
Myasthenia gravis
Myasthenia gravisMyasthenia gravis
INTRA VENOUS INDUCING AGENTS
INTRA VENOUS INDUCING AGENTS INTRA VENOUS INDUCING AGENTS
INTRA VENOUS INDUCING AGENTS
Agrawal N.K
 
Magnesium and anaesthesia
Magnesium and anaesthesiaMagnesium and anaesthesia
Magnesium and anaesthesia
drmg1976
 
Pooja drugs ppt
Pooja drugs pptPooja drugs ppt
Pooja drugs ppt
pooja chauhan
 

Similar to Chemical terrorism attacks - update on antidotes - handout (20)

Medicine 5th year, 3rd lecture (Dr. Mohammad Shaikhani)
Medicine 5th year, 3rd lecture (Dr. Mohammad Shaikhani)Medicine 5th year, 3rd lecture (Dr. Mohammad Shaikhani)
Medicine 5th year, 3rd lecture (Dr. Mohammad Shaikhani)
 
Cns Mg Davidson 07.
Cns Mg Davidson 07.Cns Mg Davidson 07.
Cns Mg Davidson 07.
 
Status epilapticus
Status epilapticusStatus epilapticus
Status epilapticus
 
Antihelminthiasis.pptx
Antihelminthiasis.pptxAntihelminthiasis.pptx
Antihelminthiasis.pptx
 
Myasthenia-Gravis.pptx
Myasthenia-Gravis.pptxMyasthenia-Gravis.pptx
Myasthenia-Gravis.pptx
 
Intravenous Induction Agents by Dr. Animesh
Intravenous Induction Agents by Dr. AnimeshIntravenous Induction Agents by Dr. Animesh
Intravenous Induction Agents by Dr. Animesh
 
Non narcotic analgesics
Non narcotic analgesicsNon narcotic analgesics
Non narcotic analgesics
 
Disorders of the neuromuscular junction
Disorders of the neuromuscular junctionDisorders of the neuromuscular junction
Disorders of the neuromuscular junction
 
status epilepticus...
status epilepticus...status epilepticus...
status epilepticus...
 
Treatment of Different Types of Pain.pdf
Treatment of Different Types of Pain.pdfTreatment of Different Types of Pain.pdf
Treatment of Different Types of Pain.pdf
 
Myasthenia gravis sh
Myasthenia gravis shMyasthenia gravis sh
Myasthenia gravis sh
 
General anesthetics
General anestheticsGeneral anesthetics
General anesthetics
 
Drugs used in emergency and operation theatre
Drugs used in emergency and operation theatreDrugs used in emergency and operation theatre
Drugs used in emergency and operation theatre
 
Intravenous induction agents
Intravenous induction agentsIntravenous induction agents
Intravenous induction agents
 
Myasthenia gravis
Myasthenia gravisMyasthenia gravis
Myasthenia gravis
 
Myasthenia gravis
Myasthenia gravisMyasthenia gravis
Myasthenia gravis
 
INTRA VENOUS INDUCING AGENTS
INTRA VENOUS INDUCING AGENTS INTRA VENOUS INDUCING AGENTS
INTRA VENOUS INDUCING AGENTS
 
Myasthenia Gravis - Management
Myasthenia Gravis - ManagementMyasthenia Gravis - Management
Myasthenia Gravis - Management
 
Magnesium and anaesthesia
Magnesium and anaesthesiaMagnesium and anaesthesia
Magnesium and anaesthesia
 
Pooja drugs ppt
Pooja drugs pptPooja drugs ppt
Pooja drugs ppt
 

More from Farooq Khan

Hypothermia and cold injuries
Hypothermia and cold injuriesHypothermia and cold injuries
Hypothermia and cold injuries
Farooq Khan
 
Neurological emergencies
Neurological emergenciesNeurological emergencies
Neurological emergencies
Farooq Khan
 
Chemical burns - pathophysiology and treatment - handout
Chemical burns - pathophysiology and treatment - handoutChemical burns - pathophysiology and treatment - handout
Chemical burns - pathophysiology and treatment - handout
Farooq Khan
 
The chain of chemical survival - handout
The chain of chemical survival - handoutThe chain of chemical survival - handout
The chain of chemical survival - handout
Farooq Khan
 
Medical response to a major radiologic emergency - handout
Medical response to a major radiologic emergency - handoutMedical response to a major radiologic emergency - handout
Medical response to a major radiologic emergency - handout
Farooq Khan
 
Infectious agents of bioterrorism handout
Infectious agents of bioterrorism   handoutInfectious agents of bioterrorism   handout
Infectious agents of bioterrorism handout
Farooq Khan
 
Acute radiation syndrome - handout
Acute radiation syndrome - handoutAcute radiation syndrome - handout
Acute radiation syndrome - handout
Farooq Khan
 
Pediatric Burns - Handout
Pediatric Burns - HandoutPediatric Burns - Handout
Pediatric Burns - Handout
Farooq Khan
 
ICU Management of Pulmonary Hypertension
ICU Management of Pulmonary HypertensionICU Management of Pulmonary Hypertension
ICU Management of Pulmonary Hypertension
Farooq Khan
 
Journal Club - Mortality after Fluid Bolus in African Children with Severe In...
Journal Club - Mortality after Fluid Bolus in African Children with Severe In...Journal Club - Mortality after Fluid Bolus in African Children with Severe In...
Journal Club - Mortality after Fluid Bolus in African Children with Severe In...
Farooq Khan
 
Journal Club - Utility of Absolute and Relative Changes in Cardiac Troponin C...
Journal Club - Utility of Absolute and Relative Changes in Cardiac Troponin C...Journal Club - Utility of Absolute and Relative Changes in Cardiac Troponin C...
Journal Club - Utility of Absolute and Relative Changes in Cardiac Troponin C...
Farooq Khan
 
Journal club - Disease progression in hemodynamically stable patients present...
Journal club - Disease progression in hemodynamically stable patients present...Journal club - Disease progression in hemodynamically stable patients present...
Journal club - Disease progression in hemodynamically stable patients present...
Farooq Khan
 
Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...
Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...
Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...
Farooq Khan
 
Introduction to Injury Prevention - An interactive discussion for senior and ...
Introduction to Injury Prevention - An interactive discussion for senior and ...Introduction to Injury Prevention - An interactive discussion for senior and ...
Introduction to Injury Prevention - An interactive discussion for senior and ...
Farooq Khan
 
Emerging and Re-emerging Infectious Diseases
Emerging and Re-emerging Infectious DiseasesEmerging and Re-emerging Infectious Diseases
Emerging and Re-emerging Infectious Diseases
Farooq Khan
 
CPC Competition - Lemierre's Syndrome
CPC Competition - Lemierre's SyndromeCPC Competition - Lemierre's Syndrome
CPC Competition - Lemierre's Syndrome
Farooq Khan
 
Evaluating fitness to drive in the ED
Evaluating fitness to drive in the EDEvaluating fitness to drive in the ED
Evaluating fitness to drive in the ED
Farooq Khan
 
Approach to Fever in the Returning Traveler
Approach to Fever in the Returning TravelerApproach to Fever in the Returning Traveler
Approach to Fever in the Returning Traveler
Farooq Khan
 
CPC Competition - Pancoast Tumor
CPC Competition - Pancoast TumorCPC Competition - Pancoast Tumor
CPC Competition - Pancoast Tumor
Farooq Khan
 
Approach to fever in the transplant patient
Approach to fever in the transplant patientApproach to fever in the transplant patient
Approach to fever in the transplant patient
Farooq Khan
 

More from Farooq Khan (20)

Hypothermia and cold injuries
Hypothermia and cold injuriesHypothermia and cold injuries
Hypothermia and cold injuries
 
Neurological emergencies
Neurological emergenciesNeurological emergencies
Neurological emergencies
 
Chemical burns - pathophysiology and treatment - handout
Chemical burns - pathophysiology and treatment - handoutChemical burns - pathophysiology and treatment - handout
Chemical burns - pathophysiology and treatment - handout
 
The chain of chemical survival - handout
The chain of chemical survival - handoutThe chain of chemical survival - handout
The chain of chemical survival - handout
 
Medical response to a major radiologic emergency - handout
Medical response to a major radiologic emergency - handoutMedical response to a major radiologic emergency - handout
Medical response to a major radiologic emergency - handout
 
Infectious agents of bioterrorism handout
Infectious agents of bioterrorism   handoutInfectious agents of bioterrorism   handout
Infectious agents of bioterrorism handout
 
Acute radiation syndrome - handout
Acute radiation syndrome - handoutAcute radiation syndrome - handout
Acute radiation syndrome - handout
 
Pediatric Burns - Handout
Pediatric Burns - HandoutPediatric Burns - Handout
Pediatric Burns - Handout
 
ICU Management of Pulmonary Hypertension
ICU Management of Pulmonary HypertensionICU Management of Pulmonary Hypertension
ICU Management of Pulmonary Hypertension
 
Journal Club - Mortality after Fluid Bolus in African Children with Severe In...
Journal Club - Mortality after Fluid Bolus in African Children with Severe In...Journal Club - Mortality after Fluid Bolus in African Children with Severe In...
Journal Club - Mortality after Fluid Bolus in African Children with Severe In...
 
Journal Club - Utility of Absolute and Relative Changes in Cardiac Troponin C...
Journal Club - Utility of Absolute and Relative Changes in Cardiac Troponin C...Journal Club - Utility of Absolute and Relative Changes in Cardiac Troponin C...
Journal Club - Utility of Absolute and Relative Changes in Cardiac Troponin C...
 
Journal club - Disease progression in hemodynamically stable patients present...
Journal club - Disease progression in hemodynamically stable patients present...Journal club - Disease progression in hemodynamically stable patients present...
Journal club - Disease progression in hemodynamically stable patients present...
 
Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...
Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...
Journal Club - EMS - "Effect of adrenaline on survival in out-of-hospital car...
 
Introduction to Injury Prevention - An interactive discussion for senior and ...
Introduction to Injury Prevention - An interactive discussion for senior and ...Introduction to Injury Prevention - An interactive discussion for senior and ...
Introduction to Injury Prevention - An interactive discussion for senior and ...
 
Emerging and Re-emerging Infectious Diseases
Emerging and Re-emerging Infectious DiseasesEmerging and Re-emerging Infectious Diseases
Emerging and Re-emerging Infectious Diseases
 
CPC Competition - Lemierre's Syndrome
CPC Competition - Lemierre's SyndromeCPC Competition - Lemierre's Syndrome
CPC Competition - Lemierre's Syndrome
 
Evaluating fitness to drive in the ED
Evaluating fitness to drive in the EDEvaluating fitness to drive in the ED
Evaluating fitness to drive in the ED
 
Approach to Fever in the Returning Traveler
Approach to Fever in the Returning TravelerApproach to Fever in the Returning Traveler
Approach to Fever in the Returning Traveler
 
CPC Competition - Pancoast Tumor
CPC Competition - Pancoast TumorCPC Competition - Pancoast Tumor
CPC Competition - Pancoast Tumor
 
Approach to fever in the transplant patient
Approach to fever in the transplant patientApproach to fever in the transplant patient
Approach to fever in the transplant patient
 

Recently uploaded

Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
chandankumarsmartiso
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYDISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
NEHA GUPTA
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
chandankumarsmartiso
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 

Recently uploaded (20)

Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERYDISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
DISSERTATION on NEW DRUG DISCOVERY AND DEVELOPMENT STAGES OF DRUG DISCOVERY
 
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
Phone Us ❤8107221448❤ #ℂall #gIRLS In Dehradun By Dehradun @ℂall @Girls Hotel...
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 

Chemical terrorism attacks - update on antidotes - handout

  • 1. Adapted from Lawrence DT and Kirk MA, Chemical Terrorism Attacks: Update on Antidotes. Emerg Med Clin N Am 25 (2007) 567–595 Chemical Terrorism Attacks: Update on Antidotes Nerve agents  Vapour exposures immediate symptoms (seconds to minutes)  Dermal exposures delayed (minutes to 18 hours) Farooq Khan MDCM PGY3 FRCP-EM McGill University November 14 th 2011
  • 2. Adapted from Lawrence DT and Kirk MA, Chemical Terrorism Attacks: Update on Antidotes. Emerg Med Clin N Am 25 (2007) 567–595 Mark-1 Kit Atropine Mechanism Atropine acts at muscarinic cholinergic receptors as a competitive antagonist. It is used to counter muscarinic effects, and administration will result in drying of secretions, alleviating bronchospasm, and reversing central apnea. Given within the first 5 minutes, it can prevent organophosphate-induced seizures Delivery autoinjector is more effective than IM injections using a conventional syringe, can go through clothing or protective garments. Additional atropine doses should be administered IV once access is obtained Dosing  Field treatment for severe poisoning is three autoinjectors or 6 mg initially with retreatment q 5-10 min  The initial intravenous dose should be 2 mg for adults or 0.02 mg/kg for children  Atropine doses should be repeated q 5 min until the therapeutic endpoint is reached (ie, until pulmonary secretions are dried [reflected by improved oxygenation] and ease of breathing [or ease of ventilation])  Typical total dose required after nerve agent poisoning has ranged from 5 to 20 mg (up to 200mg in cases) Precautions. Excessive doses of atropine can result in deleterious effects including delirium, agitation, and tachycardia and hypertension. Atropine will likely not improve miosis or skeletal muscle paralysis; therefore, reversal of these effects is not a therapeutic endpoint. Benzodiazepines Indications  Any patient who has significant symptoms from nerve agent exposure to prevent seizure and neuronal damage  Infused rapidly to unresponsive patients who may have nonconvulsive seizures due to the onset of paralysis  Alleviate extreme anxiety
  • 3. Adapted from Lawrence DT and Kirk MA, Chemical Terrorism Attacks: Update on Antidotes. Emerg Med Clin N Am 25 (2007) 567–595 Dose/delivery Diazepam 10 mg IM auto-injector in the field, Midazolam IM/IV in hospital 2-PAM  Neither atropine nor benzodiazepines will alleviate symptoms affecting the nicotinic system.  Over time, nerve agents will form an irreversible covalent bond with AChE in a process termed aging.  Once aging occurs, the patient will not regain vital functions, such as muscle strength or respiratory drive, until new enzyme is synthesized (may take weeks to months)  Oxime reactivates AChE if administered before aging Indications. 2-PAM should be given to any patient exposed to an organophosphate nerve agent who is showing any systemic toxicity. This is particularly true if there are fasciculations or weakness. Dose/Delivery Mark 1 auto-injector 600mg IM per dose for the field (max 3 injections). IV preferred in hospital.  Initial dose is 1- 2 g diluted in 100mL normal saline and given over 15-30 min  Initial pediatric dose is 20 to 50 mg/kg up to 2 g  WHO recommendation >30mg/kg bolus then >8mg/kg/hour infusion to maintain therapeutic levels due to short t½ (90 min)  For severely poisoned patients: 2 g IM or slow IV infusion over 15-30 minutes then 500mg/h infusion. Precautions. Rapid delivery can cause laryngospasm, rigidity, and self-limited hypertension responding to phentolamine 5 mg IV Pediatrics  ↑minute ventilation/kg → ↑ risk with exposure  Small airways with bronchospasm and ↑secretions→ ↑rates of respiratory distress/failure  ↑prone to seizures  The dose for atropine can be up to 0.05 - 0.1 mg/kg either IV/IO/IM.  40 kg can be administered an adult (2 mg) autoinjector  20 kg can receive a 1-mg autoinjector  10 kg can receive a 0.5-mg autoinjector  The dose for 2-PAM is 25 to 50 mg/kg, up to a total of 2 g.  12 kg will be able to tolerate the dose of one 600-mg 2-PAM autoinjector  Diazepam should be dosed at 0.05 to 0.3 mg/kg IV,  > 30 kg can receive an adult autoinjector  Autoinjector needle is 1 inch, so choose site carefully Stockpile antidotes if stocks run out, glycopyrrolate (no central effects), scopolamine (more potent central effects), diphenhydramine, and jimsonweed extract can be used as alternatives
  • 4. Adapted from Lawrence DT and Kirk MA, Chemical Terrorism Attacks: Update on Antidotes. Emerg Med Clin N Am 25 (2007) 567–595 Cyanide Found in smoke inhalation, industrial accidents, suicide attempts, criminal poisonings and can be potent chemical weapon. Primary toxic action is inducing cellular hypoxia through inhibition of cytochrome oxidase, blocking oxidative phosphorylation → shift from aerobic to anaerobic metabolism causes a depletion of cellular ATP and ↑lactic acid Effects depend on dose/route/timing o CNS and cardiac toxicity because these are the most O2-sensitive systems o Concentrated exposure→ death within minutes (i.e. no time for medical intervention) o Lesser exposure→ nonspecific symptoms including shortness of breath, hyperventilation, headache, weakness, and dizziness, which can be attributed to anxiety or other exposures o Progression to confusion, lethargy, seizures, and coma. o Neurally mediated tachypnea along with an initial ↑BP o Can progress to cardiac arrest heralded by bradycardia and hypotension o Cherry red color and ↑O2 Sat Cyanide antidote kit Amyl nitrite, sodium nitrite, and sodium thiosulfate
  • 5. Adapted from Lawrence DT and Kirk MA, Chemical Terrorism Attacks: Update on Antidotes. Emerg Med Clin N Am 25 (2007) 567–595 Mechanism o Nitrites (amyl and sodium) induce methemoglobinemia o Cyanide has a ↑affinity for methemoglobin and will leave the mitochondria to bind to it and allow the mitochondria to resume oxidatitive phosphorylation. o Sodium thiosulfate acts as a sulfhydryl donor for the enzyme for the enzyme rhodanese that converts cyanide to the less-toxic renally excreted thiocyanate Indications to initiate therapy  High index of suspicion o clusters of patients, structural fire victim, high risk activity (e.g. jeweller, lab worker)  Clinical presentations o sudden LOC, seizures, HD instability without probable cause  Surrogate markers o lactate, metabolic acidoses, narrow arteriovenous O2 Sat gap Dose/delivery  Crush amyl nitrite glass pearls and inhale or administer via BMV until IV line (goal to induce 3-5% MetHb)  Then switch to sodium nitrite IV 300mg (10ml of 3% sol’n) over 2-4min,  Peds: 10mg/kg with normal Hb, 6mg/kg in anemic or unknown Hb child  Sodium thiosulfate 12.5g IV (50ml of 25% sol’n) over 10 min, peds 1.65ml/kg of 25% sol’n  Give with high-level O2 , charcoal for oral exposures Precautions  Vasodilation, tachycardia, hypotension with high doses of nitrite  ↓ O2 carrying capacity with MetHb, avoid in anemic, CO poisoned  Thiosulfate can cause hemolysis in G6PD deficiency  Thiocyanate can be toxic in renal failure (abdo pain, rash, vomiting, CNS dysfunction) Hydroxycobalamin  Combines with CN to cyanocobalamin a.k.a. Vitamin B12 (safe and renally excreted)  Low threshold of administration given safety profile  Dose o 70mg/kg, max 5g(adult dose) IV over 15 min o Each vial of 250ml contains 2.5g, which needs to be diluted in 100ml of NS to bind 250mg of CN o Repeat dosing in severe toxicity  Combine with sodium thiosulfate but either sequentially or in a different line (inactivated if in the same line)  scavenges NO and prevents hypotension  transient red discoloration of skin and mucus membranes, interferes with lab assays of bili, creat, mg, fe  otherwise safe and preferred over nitrites Mass exposure  Most patients will not have significant exposures  Patients presenting in cardiac arrest will have low survival  Reserve antidotes for those most likely to survive  Can use thiosulfate alone
  • 6. Adapted from Lawrence DT and Kirk MA, Chemical Terrorism Attacks: Update on Antidotes. Emerg Med Clin N Am 25 (2007) 567–595 Botulism  Clostridial toxins A, B, E, and F  Highly potent (LD 50 of 1μg/kg)  Food water (onset 2h-5 days), aerosolized (onset 3 days), injection  Prevents fusion of synaptic vesicles with presynaptic membrane in PNS (cannot cross BBB) prevents neurotransmission  Descending weakness, EOMs and bulbar cranial nerves (diplopia/dysarthria/dysphagia) then motor function of UE then LE. Can affect intercostals and diaphragm needing mechanical ventilation. Spared sensory and mentation.  Anti-muscarinic effects and nausea vomiting precede neurologic symptoms  Paralysis is irreversible until cleaved protein is regenerated which can last months Antitoxin  halts progression of paralysis  binds and neutralizes free botulinum toxin  indicated on clinical suspicion (clusters of patients with similar geography etc)  dose 1 vial of Ig IV over 30-60 min diluted 1:10 in NS  1% allergic reaction to horse serum based Ig  Baby-BIG is human derived and recommended in infants Thallium  Less well known toxic heavy metal odourless and colorless dissolved in water (used in myocardial scintigraphy)  Minimum lethal dose of 12mg/kg  Absorbed from GI tract, causes green discoloration of urine in 1h  Unclear if Interferes with Krebs cycle, glycolysis, and oxidative phosphorylation, or forms stable complexes with the active sulfhydryl sites on enzymes  Nonspecific symptoms (early GI, mostly neuro)  Reliable early clue for thallium toxicity is an ascending, rapidly progressive painful sensory peripheral neuropathy (feet)  Delayed alopecia (weeks) Prussian Blue  Enhances elimination by blocking enteroenteric and enterohepatic recirculation of thallium  Indicated for any patient with toxicity or known exposure  150-250 mg/kg/day divided tid until urinary thallium excretion is <0.5mg/day  No side effects except blue tears and constipation (Dissolve in 50ml of 15% mannitol as cathartic)  Can use activated charcoal as alternative if in low supply of Prussian blue
  • 7. Adapted from Lawrence DT and Kirk MA, Chemical Terrorism Attacks: Update on Antidotes. Emerg Med Clin N Am 25 (2007) 567–595 Radiation Potassium iodide (KI)  Prevents thyroid cancer in patients exposed to radioactive iodine  Subtotal protection  Must be administered within hours  Indications o Children, pregnant or lactating women with >0.05 Gy exposure o Adults over 40 with dose >5 Gy  Dose o Newborn – 1 month: 16 mg po qd o Infants and children <3 : 32 mg po qd o Children 3-18: 65 mg po qd o Adults: 130 mg po qd Prussian blue  For cesium-137 (used in radiotherapy and medical devices, could be used in dirty bomb), behaves like potassium. Physiological t½ of 50-150 days, renally excreted in 4:1 ratio with fecal excretion  ↓urine/feces excretion ratio to 1:4 and ↓t ½ by 43%  Dose 3-10g/day  FDA recommendation : 3g bid for adults, 1g tid for children 2-12 ×30days  Mostly non toxic and not absorbed, although not studied in ARS GI syndrome where there is severe inflammation of mucosa.